Acute Lymphoblastic/lymphocytic Leukemia (ALL) accounts to be second most common Leukemia in adults which involves proliferation of immature lymphoid cells in peripheral blood, bone marrow or other organs. Genetic alterations and chromosomal abnormalities during proliferation and differentiation of lymphoid precursor encourage acute Lymphoblastic/lymphocytic Leukemia. ALL treatment involves dose-intensification strategies that have significantly improved the pediatric patients’ condition ... Read more
